MIRA INFORM REPORT

 

 

Report Date :

31.05.2013

 

IDENTIFICATION DETAILS

 

Name :

ROMIKIN S.A.

 

 

Registered Office :

Paraguay 1535(1061ABC), Buenos Aires City

 

 

Country :

Argentina

 

 

Date of Incorporation :

10.10.1986

 

 

Com. Reg. No.:

113354

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Pharmaceutical and Veterinary Specialties Pharmacy

 

 

No. of Employees :

62

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Argentina

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

ARGENTINA - ECONOMIC OVERVIEW

 

Argentina benefits from rich natural resources, a highly literate population, an export-oriented agricultural sector, and a diversified industrial base. Although one of the world's wealthiest countries 100 years ago, Argentina suffered during most of the 20th century from recurring economic crises, persistent fiscal and current account deficits, high inflation, mounting external debt, and capital flight. A severe depression, growing public and external indebtedness, and an unprecedented bank run culminated in 2001 in the most serious economic, social, and political crisis in the country's turbulent history. Interim President Adolfo RODRIGUEZ SAA declared a default - at the time the largest ever - on the government's foreign debt in December of that year, and abruptly resigned only a few days after taking office. His successor, Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the US dollar in early 2002. The economy bottomed out that year, with real GDP 18% smaller than in 1998 and almost 60% of Argentines under the poverty line. Real GDP rebounded to grow by an average 8.5% annually over the subsequent six years, taking advantage of previously idled industrial capacity and labor, an audacious debt restructuring and reduced debt burden, excellent international financial conditions, and expansionary monetary and fiscal policies. Inflation also increased, however, during the administration of President Nestor KIRCHNER, which responded with price restraints on businesses, as well as export taxes and restraints, and beginning in 2007, with understating inflation data. Cristina FERNANDEZ DE KIRCHNER succeeded her husband as President in late 2007, and the rapid economic growth of previous years began to slow sharply the following year as government policies held back exports and the world economy fell into recession. The economy in 2010 rebounded strongly from the 2009 recession, but has slowed since late 2011 even as the government continued to rely on expansionary fiscal and monetary policies, which have kept inflation in the double digits. The government expanded state intervention in the economy throughout 2012. In May the Congress approved the nationalization of the oil company YPF from Spain's Repsol. The government expanded formal and informal measures to restrict imports during the year, including a requirement for pre-registration and pre-approval of all imports. In July the government also further tightened currency controls in an effort to bolster foreign reserves and stem capital flight.

Source : CIA

 


Registered Name 

 

ROMIKIN S.A.

CUIT. Nº: 30-61116362-9

 

 

Summary 

  

BEGINNER OF ACTIVITIES. INCORPORATED IN 1986. NOT PROVIDED BALANCE SHEET. NO NEGATIVE. APT FOR CURRENT CREDITS AND ADDITIONAL GUARANTEES.

 

 

Operations 

 

PHARMACEUTICAL AND VETERINARY SPECIALTIES PHARMACY

 

 

Legal Structure 

 

BUSINESS TYPE:          LIMITED COMPANY
INCORPORATED:         10/10/1986
REGISTERED:              18/12/1986 Lo.103 To.A
REGISTER NO.:            113354
DuraTiOn:                     UNTIL 18/12/2085
END OF FISCAL YEAR:   JUNE 30

 

 

Contact 

 

ACCOUNTANT: IVANNA SBROCCO

LEGAL ADDRESS AND HEADQUARTERS: Paraguay 1535(1061ABC), Buenos Aires City, Repúblic of Argentina.

PHONE:(54-11) 4872.1200
E-mail: romikin@chemogroup.com
E-mail: consultas@romikin.com.ar

 

 

Partners 

  

PRESIDENTE:                          HUGO DANIEL VALERIO
VICEPRESIDENTE:                   JORGE RUBEN CASTRO
DIRECTOR TITULAR:                MANUEL ALBERTO SOBRADO
DIRECTOR SUPLENTE:             EMILIO DANIEL PAPARIELLO
DIRECTOR SUPLENTE:             MARIA FLORENCIA BIN ASTIGARRAGA


Uso de firma: Se encuentra a cazrgo del Presidente y V.Presidente.

 

 

Corporate Stock 

 

ORDINARY SHARES:
----------------
SUBSCRIBED AND INTEGRATED $ 185.415.322.

 

 

History 

  

THE COMPANY IS A COMMERCIAL OFFICE IN ARGENTINA FROM THE GRUPO CHEMO WITH COMPANIES IN Uruguay, Paraguay AND Bolivia, DISTRIBUTING LOCALLY SEVERAL PHARMACEUTICAL PRODUCTS AND VETERINARY.

THIS ECONOMIC GROUP PROVIDES SOLUTIONS TO THE PHARMACEUTICAL AND CHEMICAL INDUSTRY WORLDWIDE THROUGH:

CHEMO MARKETING (COMMERCIAL OFFICES):
---------------
> CHEMO IBERICA, Madrid (SPAIN).
> CHEMO IBERICA, Barcelona (SPAIN).
> CHEMO LUGANO BRANCH (SWITZERLAND).
> CHEM.EAST (Hungría).
> ROMIKIN (Argentina).
> CHEMO INDIAN BRANCH (India)
> CHEMO ASIA (China)

BUSINESS ALIANCES:
------------------
> NOSCH (India)
> OSMOTICA (SPAIN)
> MITHRA (BélgiUM AND Luxemburgo)
> EFFIK (FrancE, SPAIN AND ITALY)
> DALT PHARMA (Guatemala)
> MAPRIMED (Argentina)
> CHEMOTECNICA (Argentina)
> RECOMBIO (SPAIN)

CHEMO OPERATIONS (CHEMICAL IND. OF ACTIVE PRODUCTS):
-----------------
> INDUSTRIALE CHIMICA (ItalY)
> QUIMICA SINTETICA (SPAIN)
> GOLD PHARMA (China)

CHEMO OPERATIONS (PHARMACEUTICAL Ind.-FINISHED Prod.):
-----------------
> LABORATORIOS LICONSA (SPAIN)
> LABORATORIOS LEON FARMA (SPAIN)

VETERINARY PRODUCTS:
----------------------
> VETPHARMA (SPAIN)

CHEMO IS DEDICATED TO THE MANUFACTURE AND DISTRIBUTION OF FINISHED PRODUCTS IN THE PHARMACEUTICAL AND VETERINARY INDUSTRY AND RAW MATERIALS, PRODUCTS IN BETWEEN AND OTHER FINE CHEMICAL PRODUCTS.


BEFORE HAS LEGAL ADDRESS AND HEADQUARTERS: Avda.del Libertador 1068, piso 14o. ((1112), Buenos Aires City, Repúblic of Argentina.

 

 

Economic-Financial Position 

 

By new policy of the company not provided financial information to third parties.

 

 

Assets 

 

REAL ESTATE:
---------
WITHIN THE FIXED ASSETS IT IS INCLUDED  THE BUILDING DEDICATED TO ITS COMMERCIAL ACTIVITY WITH GOOD MARKET VALUE.

Avda del Libertador 1068 de CAPITAL FEDERAL
Jose M. Moreno 1460 CAPITAL FEDERAL

VEHICLES:
----------
THE COMPANY DOES NOT OWN VEHICLES.

 

 

Parent/Related Companies 

 

> GRUPO CHEMO

 

 

 

 

Commercial References Consulted 

 

PEPTIDES INTERNACIONAL ING. USA
--------------------------------
Payments: 30,60 and 90 days
Credits: u$s 3.600.000 annuals
Normal concept.

 

 

Evolution and Results 

 

It is possible to indicate that the company under commentary is dedicated to import and wholesale of  pharmaceutical and veterinary products.

These products are elaborated by companies of the Chemo Group that, in the last years, has initiated its activity in the scope of products finished with manufacture of granulated of controlled released.

Later, the group has developed to wide portfolio of generic brands and has collaborated with other companies to offer better products in the fields of generics, health of the woman, respiratory apparatus and other sanitary areas.

With such products, the holder develops the national market with positive results, being observed that  5% of its sales are made in Latin American.

As far as imports, it has carried out from Chine, Spain, Korea and other countries.

* 62 EMPLOYEES.


MAIN SUPPLIERS:
---------------
CHEMOTECNICA S.A. Argentina
MARIMED Argentina
MERICHEM Chine
ALVAN Chine
PEPTIDES INTERNATIONAL INC. USA
HWAVET TECHNOLOGIES CO LTDA.  Chine
PHYTHENAPICS SOLUTIONS S.A.  Spain

FOREIGN TRADE:
--------------
IN THE LAST 12 MONTHS IT HAS CARRIED OUT IMPORTS FOR  u$s. 29.154.834 AS FOLLOWS:

CHINE...........................U$S 23.228.966
INDIA...........................U$S  1.624.759
SPAIN...........................U$S    974.694
OTHERS..........................U$S  3.326.415

 

 

Branches 

  

WAREHOUSE: José María Moreno 1460, Buenos Aires City, Repúblic of Argentina.

 

 

Payment Record and Credit Risk 

 

BANCO PATAGONIA SUDAMERIS
CENTRAL OFFICE

CITIBANK N.A.
CENTRAL OFFICE

STANDARD BANK
Central Office

CREDICOOP COOP. LTDO.,
Central Office.

INSURANCES:
-------
LA CAJA CIA. DE SEGUROS S.A.

CREDIT RISK:
------------
MARCH 2013

BANCO CREDICOOP     $ 2.588.800
    PATAGONIA         838.000
    AMEX               52.500
    GALICIA               300
    ICBC                  300
    CITI                  300


Situation 1: Normal

 

 

Concept 

  

IT MAINTAINS CREDIT LINE WITH LOCAL AND INTERNATIONAL COMPANIES, WORKING WITH AMOUNTS OF RELATIVE IMPORTANCE.


* FULFILLMENT WITHOUT OBJECTIONS.

 

 

 

Final Opinion 

  

BASED ON THE PREVIOUS REVIEW, THE COMPANY IS VIABLE FOR CREDIT OPERATIONS OF CURRENT IMPORTANCE AND ADDITIONAL GUARANTEES.


* APT FOR CURRENT CREDIT OPERATIONS.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.10

UK Pound

1

Rs.85.13

Euro

1

Rs.72.80

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.